Error: Could not add to watchlist. X

Neurologix Inc

+ Watchlist
NRGXQ:US
OTC US
0.00
USD
0.00
0.00%
As of 20:10:00 ET on 08/21/2015.
Volume
750
Previous Close
0.00
52Wk Range
0.00 - 0.00
Volume
750
Previous Close
0.00
52Wk Range
0.00 - 0.00
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.44
Market Cap (k USD)
33.597
Shares Outstanding (m)
27.998
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Neurologix, Inc. is developing treatments for disorders of the brain and central nervous system using gene therapy and other alternative therapies. The Company's initial development efforts are focused on gene therapy for treating Parkinson's disease and epilepsy. Neurologix's core technology, NLX, is currently being tested in a human clinical trial to treat Parkinson's disease.
ADDRESS
One Bridge Plaza
Suite 605
Fort Lee, NJ 07024
United States
PHONE
1-201-592-6451
  • Clark A Johnson
    Chairman/CEO
  • Christine V Sapan
    Exec VP/Chief Development Ofcr
Show More